Please provide a comprehensive summary of NCCN guidelines for my Stage IV Lung. What are the standard treatment...
According to the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC), the first step is to conduct biomarker testing to determine the most appropriate treatment approach. Here are the key treatment pathways:
- Biomarker-Driven Treatment: According to NCCN Guidelines, testing should include:
- EGFR mutations
- ALK rearrangements
- ROS1 rearrangements
- BRAF mutations
- PD-L1 expression
- NTRK fusions
- First-line Treatment Options: The American Society of Clinical Oncology (ASCO) and NCCN recommend:
If biomarker positive:
- EGFR mutations: Targeted therapies like osimertinib
- ALK positive: ALK inhibitors like alectinib or brigatinib
- ROS1 positive: Entrectinib or crizotinib
If no actionable mutations but PD-L1 ≥50%:
- Pembrolizumab monotherapy
- Or combination chemotherapy plus immunotherapy
For PD-L1 <50%:
- Combination chemotherapy plus immunotherapy
- The National Cancer Institute (NCI) emphasizes that treatment goals for Stage IV focus on:
- Prolonging survival
- Managing symptoms
- Improving quality of life
- Controlling disease progression
Important considerations:
- Treatment choices should be individualized based on your specific biomarker results
- Performance status and overall health affect treatment options
- Clinical trials may be available and should be considered at any point
Please note: This is a general overview, and your specific treatment plan should be determined by your oncology team based on your individual case. Would you like me to elaborate on any particular aspect of these guidelines?
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Non-Small Cell Lung Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 19, 2025. Informational only — not a substitute for your oncology team.
Question asked:
Please provide a comprehensive summary of NCCN guidelines for my Stage IV Lung. What are the standard treatment options I should know about?
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lung Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Lung Cancer
- Should I get treatment at a comprehensive cancer center for Lung Cancer
- What are the standard first-line treatment options for Lung Cancer
- What should I consider when choosing between clinical trial and standard treatment for Lung Cancer
- How is metastatic Lung Cancer different from other stages
- Can early stage Lung Cancer be cured
- What imaging tests are used to stage Lung Cancer
- What stage is typical when Lung Cancer is first diagnosed
- What are the different treatment options for jennifer nichols's type and stage of lung cancer? Can you explain the...